| Date | Title | Description |
| 19.08.2026 | Interim report | Interim report
Wed, Aug 19, 2026 08:00 CET Report this content
January 1 – June 30, 2026
The second quarter in figures Net sales were TSEK 15,308 (8,791), +74%, cleared for currency effects +84%. The loss after tax was TSEK 28,893 (22,911).... |
| 28.07.2026 | SciBase announces changes in senior management | SciBase announces changes in senior management
Tue, Jul 28, 2026 09:00 CET Report this content
STOCKHOLM, Sweden – July 28, 2026 – SciBase Holding AB ("SciBase") [STO: SCIB) a leader in AI-based devices for detection and preventio... |
| 01.07.2026 | SciBase Submits FDA 510(k) to Expand Nevisense into the Largest Skin Cancer Market | SciBase Submits FDA 510(k) to Expand Nevisense into the Largest Skin Cancer Market
Wed, Jul 01, 2026 08:30 CET Report this content
STOCKHOLM, Sweden – July 1, 2026 – SciBase Holding AB ("SciBase") [STO: SCIB) a leader in AI-based ... |
| 10.06.2026 | First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase | First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase
Wed, Jun 10, 2026 08:45 CET Report this content
STOCKHOLM, Sweden – June 10, 2026 – SciBase Ho... |
| 09.06.2026 | Study that highlights Nevisense potential for prediction of AD published in leading journal | Study that highlights Nevisense potential for prediction of AD published in leading journal
Tue, Jun 09, 2026 13:00 CET Report this content
STOCKHOLM, Sweden – June 9, 2026 – SciBase Holding AB (“SciBase”) [STO: SCIB], a leading developer o... |
| 28.05.2026 | SciBase announces that the board of directors has resolved on the record date for the reverse share split | SciBase announces that the board of directors has resolved on the record date for the reverse share split
Thu, May 28, 2026 20:00 CET Report this content
SWEDEN – May 28, 2026 - SciBase Holding AB ("SciBase") [STO: SCIB], a leader... |
| 28.05.2026 | Nevisense detects skin barrier damage by chemicals used in household cleaning products in a new ex-vivo study | Nevisense detects skin barrier damage by chemicals used in household cleaning products in a new ex-vivo study
Thu, May 28, 2026 08:00 CET Report this content
SWEDEN – May 28, 2026 - SciBase Holding AB ("SciBase") [STO: SCIB], a le... |
| 19.05.2026 | Bulletin from the annual general meeting in SciBase Holding AB (publ) | Bulletin from the annual general meeting in SciBase Holding AB (publ)
Tue, May 19, 2026 11:30 CET Report this content
Today, the annual general meeting 2026 has been held in SciBase Holding AB (publ) ("SciBase" or the "Compan... |
| 18.05.2026 | SciBase Announces New Research Highlighting Nevisense’s Potential in Detecting Age-Related Skin Barrier Changes | SciBase Announces New Research Highlighting Nevisense’s Potential in Detecting Age-Related Skin Barrier Changes
Mon, May 18, 2026 08:00 CET Report this content
STOCKHOLM, Sweden – May 18, 2026 – SciBase Holding AB (“SciBase”) [STO: SCIB], a... |
| 07.05.2026 | Interim report | Interim report
Thu, May 07, 2026 08:00 CET Report this content
January 1 – March 31, 2026
The first quarter in figures Net sales were TSEK 14,278 (8,856), +61%, cleared for currency effects +80%. The loss after tax was TSEK 24,490 (20,682).... |
| 27.04.2026 | SciBase publishes the Annual report for 2025 | SciBase publishes the Annual report for 2025
Mon, Apr 27, 2026 16:00 CET Report this content
SciBase hereby announces that the Annual report for 2025 is available at the Company’s website www.scibase.com.
A pdf-version of the annual report ... |
| 14.04.2026 | Notice to attend the annual general meeting in Scibase Holding AB (publ) | Notice to attend the annual general meeting in Scibase Holding AB (publ)
Tue, Apr 14, 2026 09:00 CET Report this content
Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to the a... |
| 07.04.2026 | SciBase reaches milestone with over 400,000 tests sold with Nevisense | SciBase reaches milestone with over 400,000 tests sold with Nevisense
Tue, Apr 07, 2026 08:00 CET Report this content
STOCKHOLM, Sweden – April 7, 2026 – SciBase Holding AB (“SciBase”) [STO: SCIB], a leading developer of AI-based diagnostic... |
| 13.03.2026 | Interim report | Interim report
Fri, Mar 13, 2026 08:00 CET Report this content
January 1 – December 31, 2025
The fourth quarter in figures Net sales were TSEK 12,475 (8,598), +45%, cleared for currency effects +57%. The loss after tax was TSEK 25,300 (21,6... |
| 10.03.2026 | New Study Positions Nevisense’s EIS as a valuable and sensitive tool for assessing skin barrier impairment | New Study Positions Nevisense’s EIS as a valuable and sensitive tool for assessing skin barrier impairment
Tue, Mar 10, 2026 13:00 CET Report this content
STOCKHOLM, Sweden – March 10, 2026 – SciBase Holding AB (“SciBase”) [STO: SCIB], a le... |
| 05.03.2026 | New Publication: US clinicians’ real-world Nevisense experience improves melanoma detection | New Publication: US clinicians’ real-world Nevisense experience improves melanoma detection
Thu, Mar 05, 2026 08:00 CET Report this content
STOCKHOLM, Sweden – March 5, 2026 – SciBase Holding AB (“SciBase”) [STO: SCIB], a leading developer ... |
| 02.03.2026 | SciBase receives approval by FDA for extended labelling in the US | SciBase receives approval by FDA for extended labelling in the US
Mon, Mar 02, 2026 08:00 CET Report this content
STOCKHOLM, Sweden – March 2, 2026 – SciBase Holding AB (“SciBase”) [STO: SCIB], a leading developer of AI-based diagnostic sol... |
| 19.02.2026 | SciBase’s Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma which supports the use of EIS in the detection of melanoma | SciBase’s Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma which supports the use of EIS in the detection of melanoma
Thu, Feb 19, 2026 13:30 CET Report this content
STOCKHOLM, Sweden – February 19, 2026 – SciBase Holding AB ... |
| 17.02.2026 | A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns | A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns
Tue, Feb 17, 2026 15:00 CET Report this content
STOCKHOLM, Sweden – February 17, 2026 – SciBase Holding AB (“SciBase”) [STO: SCIB], a leading developer of AI-... |
| 06.02.2026 | Recalculation of warrants of series TO 2 following rights issue and updated last day of trading in BTA from the rights issue | Recalculation of warrants of series TO 2 following rights issue and updated last day of trading in BTA from the rights issue
Fri, Feb 06, 2026 08:00 CET Report this content
In accordance with the terms and conditions for warrants of series ... |
| 26.01.2026 | Change of date for publication of the year-end report for the financial year 2025 | Change of date for publication of the year-end report for the financial year 2025
Mon, Jan 26, 2026 17:45 CET Report this content
The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has resol... |
| 22.01.2026 | Increased commitment in SciBase rights issue | Increased commitment in SciBase rights issue
Thu, Jan 22, 2026 15:15 CET Report this content
STOCKHOLM, Sweden – January 22, 2026 – SciBase Holding AB (“SciBase”) [STO: SCIB], a leading developer of AI-based diagnostic solutions for skin di... |
| 09.01.2026 | SciBase publishes information document regarding rights issue | SciBase publishes information document regarding rights issue
Fri, Jan 09, 2026 15:45 CET Report this content
The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") publishes information documen... |
| 11.12.2025 | SciBase Expands Its Intellectual Property Portfolio to include the analysis of the epithelial skin barrier with New European Patent | SciBase Expands Its Intellectual Property Portfolio to include the analysis of the epithelial skin barrier with New European Patent
Thu, Dec 11, 2025 15:00 CET Report this content
STOCKHOLM, Sweden – December 11, 2025 – SciBase Holding AB (... |
| 05.12.2025 | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ)
Fri, Dec 05, 2025 10:00 CET Report this content
Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the &quo... |
| 05.12.2025 | SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2 | SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2
Fri, Dec 05, 2025 18:00 CET Report this content
SciBase Holding AB (publ) ("SciBase" or the "Company") publishe... |
| 14.11.2025 | Notice to attend the extraordinary general meeting in Scibase Holding AB (publ) | Notice to attend the extraordinary general meeting in Scibase Holding AB (publ)
Fri, Nov 14, 2025 08:00 CET Report this content
Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned t... |
| 07.11.2025 | The Board of Directors in SciBase resolves on an offer to repurchase outstanding warrants of series TO 2 and intends to resolve on a rights issue of shares of approximately SEK 83 million | The Board of Directors in SciBase resolves on an offer to repurchase outstanding warrants of series TO 2 and intends to resolve on a rights issue of shares of approximately SEK 83 million
Fri, Nov 07, 2025 08:15 CET Report this content
The ... |
| 07.11.2025 | SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million | SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million
Fri, Nov 07, 2025 08:00 CET Report this content
STOCKHOLM, Sweden – November 7, 2025 – SciBase Holding AB (“SciBase”) ... |
| 07.11.2025 | Interim report | Interim report
Fri, Nov 07, 2025 08:30 CET Report this content
January 1 – September 30, 2025
The third quarter in figures Net sales were TSEK 10,339 (8,408), +23%, cleared for currency effects +29%. The loss after tax was TSEK 18,832 (17,7... |
| 22.10.2025 | Nomination Committee appointed for SciBase Holding’s Annual General Meeting in 2026 | Nomination Committee appointed for SciBase Holding’s Annual General Meeting in 2026
Wed, Oct 22, 2025 08:00 CET Report this content
The following people have been appointed as members of SciBase Holding’s nominating committee for the Annual... |
| 26.09.2025 | Nevisense Used in Fundamental Skin Barrier Research on Atopic Dermatitis | Nevisense Used in Fundamental Skin Barrier Research on Atopic Dermatitis
Fri, Sep 26, 2025 09:00 CET Report this content
SWEDEN – September 26, 2025 - SciBase Holding AB ("SciBase") [STO: SCIB], a leader in AI-based devices for de... |
| 23.09.2025 | SciBase receives initial order for clinical study from Castle Biosciences | SciBase receives initial order for clinical study from Castle Biosciences
Tue, Sep 23, 2025 08:00 CET Report this content
SWEDEN – September 23, 2025 - SciBase Holding AB ("SciBase") [STO: SCIB], a leader in AI-based devices for d... |
| 10.09.2025 | Main owners strengthen their position in SciBase | Main owners strengthen their position in SciBase
Wed, Sep 10, 2025 10:15 CET Report this content
SWEDEN – September 10, 2025 - SciBase Holding AB ("SciBase") [STO: SCIB], a leader in AI-based devices for detection and prevention i... |
| 28.08.2025 | New Clinical Publication in Karger Dermatology Confirms Reader Studies as Key to Validating Nevisense | New Clinical Publication in Karger Dermatology Confirms Reader Studies as Key to Validating Nevisense
Thu, Aug 28, 2025 13:00 CET Report this content
SWEDEN – August 28, 2025 - SciBase Holding AB ("SciBase") [STO: SCIB], a leader ... |
| 19.08.2025 | Interim report | Interim report
Tue, Aug 19, 2025 08:00 CET Report this content
January 1 – June 30, 2025
The second quarter in figures Net sales were TSEK 8,791 (6,641), +32%, cleared for currency effects +40%. The loss after tax was TSEK 26,589 (15,050). ... |
| 01.08.2025 | SciBase announces outcome in directed share issue | SciBase announces outcome in directed share issue
Fri, Aug 01, 2025 09:00 CET Report this content
On 16 June 2025, SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Company's Board of Directors re... |
| 09.07.2025 | SciBase Launches Nevisense Pilot at Leading University in Southeast Florida | SciBase Launches Nevisense Pilot at Leading University in Southeast Florida
Wed, Jul 09, 2025 08:00 CET Report this content
SWEDEN – July 9, 2025 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intel... |
| 07.07.2025 | A new important customer in the US, Palm Beach Dermatology Group, has placed an initial order for 6 Nevisense. | A new important customer in the US, Palm Beach Dermatology Group, has placed an initial order for 6 Nevisense.
Mon, Jul 07, 2025 13:00 CET Report this content
SWEDEN – July 7, 2025 - SciBase Holding AB ("SciBase") [STO: SCIB], a l... |
| 30.06.2025 | SciBase announces outcome in directed share issue | SciBase announces outcome in directed share issue
Mon, Jun 30, 2025 13:30 CET Report this content
On 23 June 2025, SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Company's board of directors re... |
| 23.06.2025 | SciBase resolves on a directed share issue of approximately SEK 11 million | SciBase resolves on a directed share issue of approximately SEK 11 million
Mon, Jun 23, 2025 18:00 CET Report this content
The board of directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today, in ac... |
| 18.06.2025 | SciBase and Castle Biosciences: A New Era in Dermatological Diagnostics | In the world of dermatology, innovation is the lifeblood that keeps the field thriving. Recently, SciBase Holding AB, a Swedish medical technology company, made waves by signing a collaboration and license agreement with Castle Biosciences,... |
| 17.06.2025 | Bulletin from the annual general meeting in SciBase Holding AB (publ) | Bulletin from the annual general meeting in SciBase Holding AB (publ)
Tue, Jun 17, 2025 11:00 CET Report this content
Today, the annual general meeting 2025 has been held in SciBase Holding AB (publ) ("SciBase" or the "Compan... |
| 16.06.2025 | SciBase resolves on a directed share issue of SEK 19 million and announces its intention to carry out an additional directed share issue of approximately SEK 11 million | SciBase resolves on a directed share issue of SEK 19 million and announces its intention to carry out an additional directed share issue of approximately SEK 11 million
Mon, Jun 16, 2025 22:35 CET Report this content
The board of directors ... |
| 16.06.2025 | SciBase has signed a Collaboration and License Agreement with Castle Biosciences to develop diagnostic tests within dermatology and intends to carry out a directed share issue of approximately MSEK 30 | SciBase has signed a Collaboration and License Agreement with Castle Biosciences to develop diagnostic tests within dermatology and intends to carry out a directed share issue of approximately MSEK 30
Mon, Jun 16, 2025 22:30 CET Report this... |
| 10.06.2025 | SciBase's Bold Moves: Expanding Access to Melanoma Detection | In the world of healthcare, access is everything. SciBase Holding AB, a Swedish company, is making waves with its innovative approach to melanoma detection. The launch of the Nevisense Self-Pay Program in the United States marks a significa... |
| 09.06.2025 | SciBase Initiates Self-Pay Model in the US to Make Nevisense Test More Accessible to Patients | SciBase Initiates Self-Pay Model in the US to Make Nevisense Test More Accessible to Patients
Mon, Jun 09, 2025 15:00 CET Report this content
SWEDEN – June 9, 2025 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer ... |
| 04.06.2025 | SciBase Expands Further Through European Market with First Sales Order to customer in Italy | SciBase Expands Further Through European Market with First Sales Order to customer in Italy
Wed, Jun 04, 2025 10:30 CET Report this content
SWEDEN – June 4, 2025 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of... |
| 28.05.2025 | SciBase: Pioneering Early Detection in Dermatology | In the realm of medical technology, few companies shine as brightly as SciBase. This Swedish firm is not just another player in the healthcare game; it’s a beacon of hope for those battling skin disorders. With its innovative Nevisense plat... |
| 27.05.2025 | SciBase reaches milestone with over 300,000 patients tested with Nevisense | SciBase reaches milestone with over 300,000 patients tested with Nevisense
Tue, May 27, 2025 13:00 CET Report this content
SWEDEN – May 27, 2025 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intell... |
| 23.05.2025 | SciBase publishes the Annual report for 2024 | SciBase publishes the Annual report for 2024
Fri, May 23, 2025 15:00 CET Report this content
SciBase hereby announces that the Annual report for 2024 is available at the Company’s website www.scibase.com.
A pdf-version of the annual report ... |
| 15.05.2025 | Viaplay Group's Strategic Move: A Deep Dive into Share Repurchase and Financial Performance | On May 13, 2025, Viaplay Group AB made headlines with its decision to acquire its own class B shares. This strategic maneuver, authorized by the Annual General Meeting, aims to bolster the company’s long-term incentive program (LTIP 2025). ... |
| 14.05.2025 | Notice to attend the annual general meeting in Scibase Holding AB (publ) | Notice to attend the annual general meeting in Scibase Holding AB (publ)
Wed, May 14, 2025 15:00 CET Report this content
Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to the a... |
| 13.05.2025 | Interim report | Interim report
Tue, May 13, 2025 08:00 CET Report this content
January 1 – March 31, 2025
The first quarter in figures Net sales were TSEK 8,856 (6,057), +46%. The loss after tax was TSEK 27,510 (10,861). The loss per share was SEK 0.09 (0.... |
| 11.04.2025 | SciBase launches next generation Nevisense | SciBase launches next generation Nevisense
Fri, Apr 11, 2025 15:30 CET Report this content
SWEDEN – April 11, 2025 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions for ski... |
| 01.03.2025 | OssDsign and SciBase: Pioneering Advances in Medical Technology | In the world of medical technology, innovation is the lifeblood that fuels progress. Two companies, OssDsign and SciBase, are making waves with their recent developments. Both are focused on enhancing patient outcomes through advanced produ... |
| 25.02.2025 | Year-end report | Year-end report
Tue, Feb 25, 2025 08:00 CET Report this content
January 1 – December 30, 2024
The fourth quarter in figures Net sales were TSEK 8,598 (5,764), +49%. The loss after tax was TSEK 17,462 (20,541). The loss per share was SEK 0.0... |
| 21.02.2025 | New study shows significant improved clinical accuracy with Nevisense for both US and German dermatologists | New study shows significant improved clinical accuracy with Nevisense for both US and German dermatologists
Fri, Feb 21, 2025 08:00 CET Report this content
STOCKHOLM, SWEDEN, - February 21, 2025 - SciBase Holding AB ("SciBase") [S... |
| 30.01.2025 | SciBase continues US expansion, on-boards Several US Dermatology Practices that Specialize in Skin Cancer Detection | SciBase continues US expansion, on-boards Several US Dermatology Practices that Specialize in Skin Cancer Detection
Thu, Jan 30, 2025 13:00 CET Report this content
STOCKHOLM, SWEDEN, - January 30, 2025 - SciBase Holding AB ("SciBase&qu... |
| 29.01.2025 | Navigating the Corporate Landscape: Key Developments in European Companies | In the fast-paced world of corporate governance and finance, recent developments in European companies reveal the intricate dance of strategy, leadership, and innovation. From board elections to share programs, these movements shape the fut... |
| 29.01.2025 | Nevisense: A New Dawn in Skin Cancer Detection | In the world of dermatology, the battle against skin cancer is relentless. Every year, millions face the specter of malignant lesions. Yet, a beacon of hope shines through the fog of uncertainty: Nevisense. This innovative technology is not... |
| 28.01.2025 | New review article highlights Nevisense effectiveness in identifying malignant skin lesions | New review article highlights Nevisense effectiveness in identifying malignant skin lesions
Tue, Jan 28, 2025 08:00 CET Report this content
STOCKHOLM, SWEDEN, - January 28, 2025 - SciBase Holding AB ("SciBase") [STO: SCIB], a lead... |
| 27.01.2025 | Recalculation of warrants of series TO 2 following rights issue | Recalculation of warrants of series TO 2 following rights issue
Mon, Jan 27, 2025 08:00 CET Report this content
In accordance with the terms and conditions for warrants of series TO 2, which were issued in connection with the capital raise ... |
| 23.01.2025 | Nevisense (EIS) included in updated German (S1) imaging guidelines. | Nevisense (EIS) included in updated German (S1) imaging guidelines.
Thu, Jan 23, 2025 16:30 CET Report this content
Stockholm, SWEDEN. January 23, 2025 - SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented ... |
| 14.01.2025 | The Rise of Biometric Technology in Air Travel: Checkin.com Group's Strategic Move | In a world where technology evolves at lightning speed, the travel industry is no exception. Checkin.com Group has recently signed a significant agreement with WestJet Group, a major North American airline. This partnership marks a pivotal ... |
| 14.01.2025 | SciBase announces final outcome of directed issue and rights issue | SciBase announces final outcome of directed issue and rights issue
Tue, Jan 14, 2025 18:00 CET Report this content
SciBase Holding AB (”SciBase” or the ”Company”) today announces the final outcome of the capital raise, consisting of a right... |
| 13.01.2025 | SciBase announces outcome of directed issue and preliminary outcome of rights issue | SciBase announces outcome of directed issue and preliminary outcome of rights issue
Mon, Jan 13, 2025 20:00 CET Report this content
SciBase Holding AB (”SciBase” or the ”Company”) today announces the preliminary outcome of the capital raise... |
| 03.01.2025 | The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot | The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot
Fri, Jan 03, 2025 08:00 CET Report this content
Stockholm, SWEDEN. January 3, 2025 - SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmente... |
| 28.12.2024 | Cereno Scientific Expands Access to Innovative Treatment for Pulmonary Arterial Hypertension | Cereno Scientific is making waves in the biotech ocean. The company has enrolled nine additional patients in its Expanded Access Program (EAP) for CS1, a promising drug candidate aimed at treating pulmonary arterial hypertension (PAH). This... |
| 27.12.2024 | Today the subscription period in SciBase rights issue begins | Today the subscription period in SciBase rights issue begins
Fri, Dec 27, 2024 08:00 CET Report this content
Today, on December 27, 2024, is the first day of the subscription period in SciBase Holding AB's (“SciBase” or the “Company”) right... |
| 20.12.2024 | SciBase letter from the CEO | SciBase letter from the CEO
Fri, Dec 20, 2024 13:15 CET Report this content
In 2024, SciBase has advanced its positions significantly and laid the foundation for continued growth, with a new organization in the US, success within the skin b... |
| 19.12.2024 | Navigating the Corporate Landscape: SciBase and Probi's Strategic Moves | In the ever-evolving world of corporate finance, two companies recently made headlines: SciBase Holding AB and Probi AB. Both firms are navigating the waters of capital restructuring and acquisition offers, showcasing the dynamic nature of ... |
| 19.12.2024 | SciBase and Cereno Scientific: Navigating the Waters of Innovation and Investment | In the world of biotechnology and medical technology, companies like SciBase Holding AB and Cereno Scientific are charting their courses through turbulent waters. Both firms are making waves with their recent announcements, showcasing their... |
| 13.12.2024 | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ)
Fri, Dec 13, 2024 11:00 CET Report this content
Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the &quo... |
| 13.11.2024 | Zinzino and SciBase: Pioneering Health Innovations in Global Markets | In the world of health and wellness, two companies are making waves. Zinzino AB and SciBase Holding AB are charting new territories. Their recent announcements reveal ambitious plans and groundbreaking innovations. Both companies are driven... |
| 13.11.2024 | SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient | SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient
Wed, Nov 13, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - November 13, 2024 - SciBase Holding AB ("SciBase") [... |
| 12.11.2024 | The Future of Health: Innovations in Biotechnology and Dermatology | In the ever-evolving landscape of healthcare, two companies stand out: Circio Holding ASA and SciBase Holding AB. Both are pioneers in their fields, pushing the boundaries of science to improve patient outcomes. Their recent announcements r... |
| 12.11.2024 | SciBase decides on a directed issue of approximately SEK 22.5 million and a rights issue of up to approximately SEK 59.3 million | SciBase decides on a directed issue of approximately SEK 22.5 million and a rights issue of up to approximately SEK 59.3 million
Tue, Nov 12, 2024 08:45 CET Report this content
The Board of Directors of SciBase Holding AB (publ) (“SciBase” ... |
| 12.11.2024 | Interim report January 1 – September 30, 2024 | Interim report January 1 – September 30, 2024
Tue, Nov 12, 2024 08:50 CET Report this content
January 1 – September 30, 2024
The third quarter in figures Net sales were TSEK 8,408 (7,248), +16%. The loss after tax was TSEK 17,753 (12,786). ... |
| 12.11.2024 | Notice to extraordinary general meeting in Scibase Holding AB (publ) | Notice to extraordinary general meeting in Scibase Holding AB (publ)
Tue, Nov 12, 2024 18:00 CET Report this content
Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to an extrao... |
| 12.11.2024 | SciBase announces collaboration for prediction of atopic dermatitis in infants | SciBase announces collaboration for prediction of atopic dermatitis in infants
Tue, Nov 12, 2024 13:00 CET Report this content
November 12, 2024 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-base... |
| 30.10.2024 | SciBase initiates sales collaboration in Italy | SciBase initiates sales collaboration in Italy
Wed, Oct 30, 2024 13:00 CET Report this content
SWEDEN, - October 30, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions ... |
| 21.10.2024 | SciBase continues US expansion and will attend Fall Clinical conference | SciBase continues US expansion and will attend Fall Clinical conference
Mon, Oct 21, 2024 08:00 CET Report this content
SWEDEN, - Oct 21, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intellig... |
| 15.10.2024 | SciBase and Cereno Scientific: Pioneering Innovations in Healthcare | In the ever-evolving landscape of healthcare, two companies stand out: SciBase Holding and Cereno Scientific. Both are on the cutting edge of medical technology and pharmaceuticals, each addressing critical health issues with innovative sol... |
| 14.10.2024 | Nomination Committee appointed for SciBase Holding’s Annual General Meeting in 2025 | Nomination Committee appointed for SciBase Holding’s Annual General Meeting in 2025
Mon, Oct 14, 2024 08:00 CET Report this content
The following people have been appointed as members of SciBase Holding’s nominating committee for the Annual... |
| 27.09.2024 | SciBase announces sale of Nevisense to NIH (US) | SciBase announces sale of Nevisense to NIH (US)
Fri, Sep 27, 2024 13:00 CET Report this content
SWEDEN, - Sept 27, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], pioneering prevention and prediction in dermatology disorders is... |
| 26.09.2024 | SciBase expands to new market in Pennsylvania and receives first order from large dermatology practice | SciBase expands to new market in Pennsylvania and receives first order from large dermatology practice
Thu, Sep 26, 2024 14:00 CET Report this content
SWEDEN, - Sept 26, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], pioneerin... |
| 02.09.2024 | New US Consensus Report supports Nevisense | New US Consensus Report supports Nevisense
Mon, Sep 02, 2024 08:45 CET Report this content
Consensus reached by top US clinicians assessing technologies for melanoma detection and management
The report concludes that the Nevisense AI-driven... |
| 21.08.2024 | Shifting Gears in Biotech: SciBase and AAX Biotech Make Strategic Moves | In the fast-paced world of biotechnology, change is the only constant. Companies must adapt, evolve, and sometimes pivot to stay relevant. Recently, two Swedish biotech firms, SciBase and AAX Biotech, made significant announcements that ref... |
| 21.08.2024 | Interim report | Interim report
Wed, Aug 21, 2024 08:00 CET Report this content
January 1 – June 30, 2024
The second quarter in figures Net sales were TSEK 6,641 (5,085), +31%. The loss after tax was TSEK 15,050 (11,352). The loss per share was SEK 0.08 (0.... |
| 21.08.2024 | SciBase changes Certified Adviser to Carnegie Investment Bank AB (publ). | SciBase changes Certified Adviser to Carnegie Investment Bank AB (publ).
Wed, Aug 21, 2024 09:00 CET Report this content
STOCKHOLM, SWEDEN, 21 August 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], SciBase], a leading developer... |
| 28.06.2024 | SciBase partner with a large health care group in Los Angeles, Unified Health, and receives a first order | SciBase partner with a large health care group in Los Angeles, Unified Health, and receives a first order
Fri, Jun 28, 2024 11:30 CET Report this content
STOCKHOLM, SVERIGE, 28 June 2024 - SciBase Holding AB ("SciBase") [STO: SCIB... |
| 13.06.2024 | SciBase welcomes new chairman and thanks the former | SciBase welcomes new chairman and thanks the former
Thu, Jun 13, 2024 16:30 CET Report this content
STOCKHOLM, SVERIGE, 13 June 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], SciBase, a leading developer of AI-based solutions ... |
| 13.06.2024 | SciBase strengthens the US organization with experienced leader in dermatology | SciBase strengthens the US organization with experienced leader in dermatology
Thu, Jun 13, 2024 13:00 CET Report this content
STOCKHOLM, SVERIGE, 13 June 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], SciBase, a leading devel... |
| 31.05.2024 | Today is the first day of trading in the new shares and warrants of series TO 2 issued in connection with the completed capital raising | Today is the first day of trading in the new shares and warrants of series TO 2 issued in connection with the completed capital raising
Fri, May 31, 2024 07:45 CET Report this content
Today, 31 May 2024, trading in the new shares and warran... |
| 31.05.2024 | Interim report | Interim report
Fri, May 31, 2024 08:00 CET Report this content
January 1 –March 31, 2024
The first quarter in figures Net sales were TSEK 6,057 (5,149), +18%. The loss after tax was TSEK 10,861 (10,906). The loss per share was SEK 0.09 (0.1... |
| 30.05.2024 | SciBase receives first order in Austria | SciBase receives first order in Austria
Thu, May 30, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - May 30, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of artificial intelligence (AI)-based solu... |
| 29.05.2024 | SciBase Announces the launch of eBarrier Score, the First AI-Driven Skin Barrier Assessment tool for research and Cosmetic Testing | SciBase Announces the launch of eBarrier Score, the First AI-Driven Skin Barrier Assessment tool for research and Cosmetic Testing
Wed, May 29, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - May 29, 2024 - SciBase Holding AB ("... |
| 22.05.2024 | New German study shows Nevisense significantly improves dermatologists clinical decisions | New German study shows Nevisense significantly improves dermatologists clinical decisions
Wed, May 22, 2024 13:30 CET Report this content
STOCKHOLM, SWEDEN, - May 22, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading de... |
| 22.05.2024 | SciBase publishes the Annual report for 2023 | SciBase publishes the Annual report for 2023
Wed, May 22, 2024 09:00 CET Report this content
SciBase hereby announces that the Annual report for 2023 is available at the Company’s website www.scibase.com.
A pdf-version of the annual report ... |
